Tyrx presents early clinical results from AIGISRXTM antibacterial envelope retrospective registry

News | 05. 14. 2009

TYRX

 
Monmouth, NJ, (May 22, 2009) — TYRX, Inc., a leader in the commercialization of implantable medical-pharmaceutical devices announced today at the 30th Annual Scientific Sessions of the Heart Rhythm Society the initial, interim clinical results from its AIGISRXTM Antibacterial Envelope Retrospective Registry.